ESMO Breast Cancer 2023 Congress Coverage

 

ESMO Breast Cancer 2023 Congress Coverage
H

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analysis: T-DXd vs. TPC in HER2-Low Unresectable and/or Metastatic BC

By ESMO Breast Cancer 2023 Congress Coverage FEATURING Hope Rugo
By ESMO Breast Cancer 2023 Congress Coverage FEATURING Hope Rugo
0 views
May 25, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Videos
19:34
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

Feat. H. McArthur
10:48
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window o…

Feat. M. Oliveira
16:20
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early B…

Feat. S. Lee
07:49
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

Feat. H. Rugo
17:44
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

Feat. H. Rugo
14:38
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clini…

Feat. K. Gelmon
17:03
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Presen…

Feat. C. Criscitiello
10:06
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib …

Feat. T. Tan
14:11
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

Feat. P. Tarantino
16:58
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identif…

Feat. J. Balko
09:56
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients …

Feat. J. Cortes
05:47
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Pred…

Feat. S. Lammers